Skip to menu Skip to content Skip to footer

Targeting human CLEC9A+ dendritic cells as a new strategy for cancer immunotherapy (2015-2017)

Experts

Honorary Professor Kristen Radford

Honorary Professor
Mater Research Institute-UQ
Faculty of Medicine
Kristen Radford
Kristen Radford